HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms.

Abstract
14q-deletions have been repeatedly described in mature B-cell neoplasms, but not yet characterized in a larger cohort. Based on chromosome banding analysis, the present study identified 47 del(14q) cases in 3054 mature B-cell neoplasms (1·5%) (chronic lymphocytic leukaemia [CLL]: 1·9%; CLL/prolymphocytic leukaemia [PL]: 9·0%; others: 0·2%). Interphase fluorescence in situ hybridization was performed with probes for 14q22.1, 14q24.1, 14q32.33, and IGH@ (14q32.3). The del(14q) had heterogeneous size but showed a breakpoint cluster at the centromeric site in 14q24.1 (62% of cases). At the telomeric side, the most frequent breakpoint was within the IGH@ locus (14q32.3) between IGH@ 3'-flanking and IGHV (IgVH) probes (45%). In 16 cases (34%), breakpoints occurred within 14q24.1 and 14q32.3. Eighty-one percent of del(14q) cases showed 1-3 additional cytogenetic alterations (in 45%, +12), and 56% were IGHV-unmutated. In all cases (16/16) with breakpoints in 14q24.1 and 14q32.3, a B-CLL immunophenotype was found. Clinical follow-up in 32 del(14q) patients was compared to 383 CLL and CLL/PL patients without del(14q). While 3-year-overall survival did not differ significantly, time to treatment was significantly shorter in the del(14q) cohort (21·0 months vs. 80·1 months, P = 0·015). In conclusion, the del(14q) is a rare recurrent alteration in diverse mature B-cell neoplasms, shows variable size but distinct clustering of breakpoints, and is associated with short time to treatment.
AuthorsLena Reindl, Ulrike Bacher, Frank Dicker, Tamara Alpermann, Wolfgang Kern, Susanne Schnittger, Torsten Haferlach, Claudia Haferlach
JournalBritish journal of haematology (Br J Haematol) Vol. 151 Issue 1 Pg. 25-36 (Oct 2010) ISSN: 1365-2141 [Electronic] England
PMID20649559 (Publication Type: Journal Article)
Copyright© 2010 Blackwell Publishing Ltd.
Chemical References
  • Immunoglobulin Heavy Chains
  • Immunoglobulin Variable Region
Topics
  • Aged
  • Aged, 80 and over
  • Chromosome Aberrations
  • Chromosome Deletion
  • Chromosomes, Human, Pair 14 (genetics)
  • Female
  • Humans
  • Immunoglobulin Heavy Chains (genetics)
  • Immunoglobulin Variable Region (genetics)
  • In Situ Hybridization, Fluorescence
  • Leukemia, Lymphocytic, Chronic, B-Cell (genetics)
  • Leukemia, Prolymphocytic (genetics)
  • Male
  • Middle Aged
  • Mutation
  • Prognosis
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: